Filters

Latest News

2017-05-31 18:18:44

IFPMA contribution to key global health discussions @WHA70 (22-31 May 2017)

Geneva, 31 May 2017 – Starting with the election of Dr Tedros Adhanom Ghebreyesus as Director-General of the World Health ...

Read More

2017-05-18 13:30:05

New Alliance to Drive and Measure Industry Progress to Curb Antimicrobial Resistance

New Industry Alliance brings together research-based pharmaceutical companies, generics, biotech and diagnostic companies, to drive ...

Read More

2017-05-02 07:50:20

Fumie Griego joins International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) as new Assistant Director General

IFPMA Director-General Thomas Cueni announced today that former PhRMA and Merck KGaA executive, Dr Fumie ...

Read More

2017-04-17 18:00:39

Progress report on biopharmaceutical industry contributions to the global fight against Neglected Tropical Diseases (NTDs)

109 active R&D projects for NTDs, of which over 90% are collaborative involving over 50 ...

Read More

2017-03-09 16:32:44

EBE, EFPIA and IFPMA have today launched a position paper entitled “Considerations for physicians on switching decisions regarding biosimilars”.

Switching describes a physician’s decision to exchange one product that a patient receives for another. ...

Read More

2017-02-28 07:57:57

IFPMA launches new policy principles and report on Rare Disease Day 2017 to benefit patients, healthcare and society

New set of policy principles outlines critical elements for a global framework on rare disease ...

Read More

2017-02-10 09:30:19

IFPMA launches its 2017 facts & figures report

Geneva, 10 February 2017 – IFPMA has just published its 2017 facts & figures report ...

Read More

Latest Statement

2017-08-30 16:15:35

IFPMA Statement on UHC at 67th Session of the WHO Regional Committee for Africa

Delivered by Cyntia Genolet, Manager, Regulatory and Health Policy 30th August, Victoria Falls, Republic of Zimbabwe – Thank you for ...

Read More

2017-08-30 14:33:29

IFPMA Statement on Yellow Fever at 67th Session of the WHO Regional Committee for Africa

Geneva, 10 February 2017 – IFPMA has just published its ...

Read More

2017-06-06 21:37:25

IFPMA Statement to New Essential Medicines List

Geneva, 10 February 2017 – IFPMA has just published its ...

Read More

2017-05-30 15:33:37

WHO WHA 70 agenda item 15.6 Cancer prevention and control in the context of an integrated approach

Geneva, 10 February 2017 – IFPMA has just published its ...

Read More

2017-05-29 13:47:29

WHO WHA 70 agenda item 15.2 Draft global action plan on the public health response to dementia

Geneva, 10 February 2017 – IFPMA has just published its ...

Read More

2017-05-29 09:01:04

WHO WHA 70 item 13.6 Member State mechanism on SSFFC

Geneva, 10 February 2017 – IFPMA has just published its ...

Read More

2017-05-27 10:35:37

WHO WHA 70 agenda item 13.3 Addressing the global shortage of, and access to, medicines and vaccines

Geneva, 10 February 2017 – IFPMA has just published its ...

Read More

mailto:s.kaenzig@ifpma.org +41 22 338 32 49
direct line
Twitter skaenzig

Sadia Kaenzig - Communications Manager

Sadia manages communications on issues including regulatory, intellectual property protection, trade and the economic footprint of the research-based pharmaceutical industry, research and development ecosystem and innovation, vaccines including influenza vaccines, and biotherapeutics.

mailto:m.depol@ifpma.org +41 22 338 32 20
direct line
Twitter @MorganePol

Morgane De Pol - Communications and Public Affairs

Morgane manages communications on issues including the research-based pharmaceutical industry’s commitment to achieving sustainable and inclusive development, advancing Universal Health Coverage, designing transformational partnerships to build healthier societies, boosting innovation for neglected tropical diseases, expanding access to high quality treatments for infectious and chronic diseases, fighting counterfeit medicines, and promoting resilient and efficient health systems.

A shared commitment to global health

Our Brouchure

2015 Edition

A shared commitment to global health

At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.


Our Logo

Full colour EPS format

Our Logo

Full colour PNG format


FULL Name LOGO

Full colour EPS format


FULL Name LOGO

Full colour PNG format

Hot Topic

Pharmacovigilance: Do your bit, play your part!

Pharmacovigilance is one of the key steps to ensuring the safety of all our medicines, including biotherapeutics and vaccines. It encourages an ongoing cycle of communication between patients, health professionals, regulatory authorities, and our biopharma industry which is

Read More

Interview

IFPMA 2015 interview series 'Biodiversity, human health, and pharma'

A must-watch: Dr Manisha A. Desai, assistant general patent counsel at Eli Lilly and Company, gives her take on the importance of the Convention of Biodiversity and the Nagoya Protocol for the pharma industry. What's key is to

Read More

Our Blog

Latest Tweets

What can we learn from Maria’s story and how can we combat #dementia? Read our op-ed & watch the video:… https://t.co/F93BLsFP51
  @IFPMA
How do our 300+ #health partnerships support #GlobalGoals & #UHC2030? Find out: https://t.co/1WB9BtMk22 #UNGA #SDGs… https://t.co/xieDJkdhre
1 1
  @IFPMA
How do we work w/ @GlobalFund to tackle #malaria? Check out our #health partnership: https://t.co/dPEE8tdmlghttps://t.co/7adqoxYkbc
1
  @IFPMA
8 mil people die each year of preventable causes in LMICs. What are we doing to achieve #UHC?… https://t.co/0lJhMdvdJ0
1
  @IFPMA